• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于威尔逊氏病治疗的亲脂性基质中硫酸锌释放的动力学研究。

Kinetic study of zinc sulphate release from lipophilic matrices prepared for the therapy of Wilson's disease.

作者信息

Nagy J, Folhoffer A, Horvath A, Csak T, Taba G, Szentmihályi K, Szalay F, Zelko R

机构信息

University Pharmacy, Department of Pharmacy Administration, Semmelweis University, Budapest, Hungary.

出版信息

Pharmazie. 2005 Jul;60(7):524-6.

PMID:16076079
Abstract

The rate and extent of drug release from the most controlled release wax matrices are influenced by the drug loading/embedding excipient ratio of the systems. In the present study hydrophobic wax - zinc sulphate matrices with different drug loadings were prepared for the therapy of Wilson's disease. The drug release was tested by the paddle method of USP and the dissolution data were analysed. Both the dissolution rate and kinetic profile can be controlled by alteration in the quantity of embedding material. Matrices of 75% zinc sulphate loadings showed steady state diffusion-controlled matrix release with good correlation in vitro. Good absorption of zinc sulphate from the gastrointestinal tract was proven by significant elevation of serum zinc level in patients with Wilson's disease.

摘要

从大多数控释蜡基质中药物释放的速率和程度受系统中药物负载/包埋辅料比例的影响。在本研究中,制备了具有不同药物负载量的疏水蜡 - 硫酸锌基质用于威尔逊病的治疗。采用美国药典桨法测试药物释放,并对溶出数据进行分析。溶出速率和动力学曲线均可通过改变包埋材料的量来控制。硫酸锌负载量为75%的基质表现出稳态扩散控制的基质释放,体外相关性良好。威尔逊病患者血清锌水平显著升高证明了胃肠道对硫酸锌的良好吸收。

相似文献

1
Kinetic study of zinc sulphate release from lipophilic matrices prepared for the therapy of Wilson's disease.用于威尔逊氏病治疗的亲脂性基质中硫酸锌释放的动力学研究。
Pharmazie. 2005 Jul;60(7):524-6.
2
Zinc sulphate release and morphology of matrices prepared for the individual therapy of Wilson's disease.用于威尔逊氏病个体化治疗的基质的硫酸锌释放及形态
Pharmazie. 2004 Apr;59(4):327-8.
3
Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.锌疗法可提高威尔逊氏病患者十二指肠中金属硫蛋白和铁的浓度。
Am J Gastroenterol. 1999 Feb;94(2):334-8. doi: 10.1111/j.1572-0241.1999.851_w.x.
4
Symptomatic copper deficiency in three Wilson's disease patients treated with zinc sulphate.三例经硫酸锌治疗的 Wilson 病患者出现症状性铜缺乏症。
Neurol Neurochir Pol. 2014;48(3):214-8. doi: 10.1016/j.pjnns.2014.05.002. Epub 2014 May 17.
5
Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.在威尔逊病中从硫酸锌-青霉胺维持治疗中停用青霉胺:有前景、安全且廉价。
J Neurol Sci. 2008 Jan 15;264(1-2):129-32. doi: 10.1016/j.jns.2007.08.006. Epub 2007 Sep 4.
6
Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.锌治疗可预防威尔逊病中的脂质过氧化并增加谷胱甘肽的可用性。
J Lab Clin Med. 2003 Jun;141(6):372-7. doi: 10.1016/S0022-2143(03)00027-1.
7
[Wilson's disease and pregnancy].[威尔逊氏病与妊娠]
Rev Esp Enferm Dig. 2002 Apr;94(4):227-8.
8
Effect of penicillamine and zinc on iron metabolism in Wilson's disease.青霉胺和锌对肝豆状核变性患者铁代谢的影响。
Scand J Gastroenterol. 2007 Dec;42(12):1495-500. doi: 10.1080/00365520701514495.
9
Treatment of Wilson's disease with zinc sulphate.用硫酸锌治疗威尔逊氏病。
Br Med J (Clin Res Ed). 1984 Sep 1;289(6444):558-9. doi: 10.1136/bmj.289.6444.558-c.
10
Oral zinc sulphate treatment in Wilson's disease.硫酸锌口服治疗肝豆状核变性
Acta Physiol Hung. 1990;75 Suppl:233-4.

引用本文的文献

1
Optimized spray-drying of zinc sulfate-loaded liposomes: physicochemical characterization and in vitro release assessment.负载硫酸锌脂质体的优化喷雾干燥:理化特性及体外释放评估
Sci Rep. 2025 Jul 1;15(1):20955. doi: 10.1038/s41598-025-05948-4.